Moore Venture Partners
Early-stage venture capital firm investing in technology and life science companies across underserved U.S. markets. Provides deal sourcing, investment screening, syndicate formation with institutional and corporate partners, and ongoing strategic and technical advisory to portfolio companies. Team includes investors, operators, engineers, scientists, and external advisors with experience in legal, regulatory, and R&D domains.
Moore Venture Partners
San Diego, California, United States, North America
Services
Venture capital investments (early-stage)
Providing equity capital to seed and early-stage technology and life science companies.
Deal sourcing and screening
Identifying and screening company opportunities across a distributed network and evaluating fit by quality, stage, and sector.
Syndicate organization and investor relations
Coordinating and organizing investment syndicates with institutional funds and corporate investors to complete financings.
Strategic and technical advisory for portfolio companies
Providing advisory services including commercialization strategy, regulatory planning, IP strategy, and technical evaluation through in-house and external experts.
Venture capital investments (early-stage)
Providing equity capital to seed and early-stage technology and life science companies.
Deal sourcing and screening
Identifying and screening company opportunities across a distributed network and evaluating fit by quality, stage, and sector.
Syndicate organization and investor relations
Coordinating and organizing investment syndicates with institutional funds and corporate investors to complete financings.
Strategic and technical advisory for portfolio companies
Providing advisory services including commercialization strategy, regulatory planning, IP strategy, and technical evaluation through in-house and external experts.
Expertise Areas
- Early-stage venture capital
- Deal sourcing and syndication
- Investment due diligence
- Startup growth and commercialization advisory
Key Technologies
- Next-generation sequencing (NGS) data analysis acceleration
- Mid-infrared quantum cascade laser technology
- Oligonucleotide-based therapeutics
- Protein biomarker discovery and validation